Corvus Pharmaceuticals Inc (CRVS) — Financial Flexibility Index
Corvus Pharmaceuticals Inc (CRVS) has a Financial Flexibility Index of -1.06x as of June 2026. Free cash flow of $-14.82 Million (operating CF $-15.40 Million minus capex $582.00K) represents -1% of total liabilities ($13.95 Million). Check Corvus Pharmaceuticals Inc (CRVS) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Corvus Pharmaceuticals Inc Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Corvus Pharmaceuticals Inc across 12 annual periods. For the full cash flow conversion analysis, see Corvus Pharmaceuticals Inc cash conversion from operations.
Annual Financial Flexibility Index for Corvus Pharmaceuticals Inc (2014–2025)
Year-by-year free cash flow to debt coverage for Corvus Pharmaceuticals Inc. Explore CRVS debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.29x | $-32.62 Million | $-32.80 Million | $9.91 Million | ▼ -370.3% |
| 2024 | -0.70x | $-25.42 Million | $-25.42 Million | $36.34 Million | ▲ +79.9% |
| 2023 | -3.48x | $-23.90 Million | $-23.93 Million | $6.87 Million | ▼ -57.7% |
| 2022 | -2.21x | $-26.75 Million | $-27.02 Million | $12.12 Million | ▲ +26.1% |
| 2021 | -2.99x | $-36.71 Million | $-36.72 Million | $12.29 Million | ▼ -15.1% |
| 2020 | -2.59x | $-34.70 Million | $-34.78 Million | $13.38 Million | ▲ +12.8% |
| 2019 | -2.98x | $-37.30 Million | $-37.32 Million | $12.54 Million | ▲ +42.2% |
| 2018 | -5.15x | $-40.63 Million | $-40.99 Million | $7.90 Million | ▼ -11.3% |
| 2017 | -4.62x | $-45.95 Million | $-46.21 Million | $9.94 Million | ▼ -32.4% |
| 2016 | -3.49x | $-25.66 Million | $-27.86 Million | $7.35 Million | ▼ -4621.2% |
| 2015 | -0.07x | $-9.58 Million | $-11.33 Million | $129.56 Million | ▼ -157.1% |
| 2014 | 0.13x | $1.64 Million | $-104.73K | $12.69 Million | — |